Europe Ophthalmology Drugs & Devices Market By Device (Surgical Device, Diagnostic and Monitoring Device, Vision Care), Drugs (Dry Eye Drugs, Retinal Disorders Drugs, Ophthalmic Anti-Allergy/Inflammatory/Infective Drugs, Anti-glaucoma Drugs, Drugs By Use Of Preservation), Drug Delivery Types (Capsules & Tablets, Gels, Eye drops, Eye Ointment, Eye Solutions), Country (Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe), Market Trends and Forecast to 2027
Market Analysis and Insights : Europe Ophthalmology Drugs and Devices Market
Ophthalmic medications are commonly used to combat eye conditions such as glaucoma, cataract, dry eyes, conjunctivitis, diabetic retinopathy, and others. The design of novel approaches for the distribution of ophthalmic medications has enabled drug manufacturers establish successful and sophisticated clinical techniques.
Ophthalmology drugs & devices market is expected to grow in the forecast period from 2020 to 2027. Data Bridge Market Research analyses the market for USD 13.81 billion by 2027, growing at a CAGR of 5.45% over the above-mentioned forecast period. The growth of Europe ophthalmology drugs & devices market is attributed to growing incidences of eye diseases.
Rising aged population along with increasing occurrence of obesity and diabetes with technical advancements in the field of ophthalmology are some of the key factors that will impact this markets growth in the forecast period of 2020 to 2027. Increasing expense of healthcare along with strict guidelines of FDA for drug approval are some key factors which restrain the market growth.
According to the Royal College of Ophthalmologists of the United Kingdom, nearly 330,000 cataract procedures are performed daily in England. It has been reported that 30% of people aged 65 and over have cataracts with visual impairment on one or both sides. Many cultures tend to have a higher incidence of cataracts. For instance, 77% of the British population aged 42 or older, born in the Indian subcontinent, has cataract. In Great Britain, the number of people undergoing cataract surgery is subject to have double variation due to differences in the drug commissioning policies.
This ophthalmology drugs & devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on ophthalmology drugs & devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Europe Ophthalmology Drugs & Devices Market Scope and Market Size
Ophthalmology Drugs and Devices Market is segmented on the basis of device, drugs and drug delivery types. Such categories allow you to evaluate progress in different niche exchanges and consumer strategy approaches and define the main areas of operation, as well as help you uncover the main difference between your target markets.
Based on the device, ophthalmology drugs & devices market is mainly segmented into three notable segments: surgical device, diagnostic & monitoring device and vision care. Ophthalmology drugs & devices market is further segmented on the basis of surgical device into glaucoma surgery devices, cataract surgery devices, refractive surgery devices, vitreoretinal surgery devices, other surgical devices. Glaucoma surgery devices segment is further sub-segmented into glaucoma drainage devices (GDD), stents and implants, glaucoma lasers and glaucoma systems. Cataract surgery devices segment is sub-segmented into intraocular lens (IOL), ophthalmic viscoelastic devices (OVD) and phacoemulsification devices. Refractive surgery devices segment is sub-segmented into excimer laser, YAG laser, microkeratome and femtosecond laser. Vitreoretinal surgery devices segment is sub-segmented into vitrectomy machines, photocoagulation lasers and illumination devices. Ophthalmology drugs & devices market is further segmented on the basis of diagnostic and monitoring device into optical coherence tomographers (OCT) scanners, fundus cameras, slit lamps, visual field analyzers/perimeters, wavefront aberrometers, ophthalmic ultrasound imaging systems, ophthalmoscopes, tonometers, autorefractors/phoropters, keratometers, corneal topographers, retinoscope, pachymeter, specular microscope, biometers, optotype projectors and dioptometers. Europe ophthalmology drugs & devices market is further segmented on the basis of vision care into spectacles and contact lens.
Optical Coherence Tomography (OCT) is a medical technology tool used to test ocular structures. The data is then used by physicians / doctors to determine the pacing of disease conditions and to validate clinical diagnosis. Subsequent OCT scans are used to test the effectiveness of diabetic retinopathy, age-related macular degeneration and glaucoma treatment.
Based on the drugs, ophthalmology drugs & devices market is segmented into dry eye drugs, retinal disorders drugs, ophthalmic anti-allergy/inflammatory/infective drugs, drugs by use of preservation and anti-glaucoma drugs. Each segment is further sub segmented into existing and pipeline drugs. And drugs by use of preservation is sub-segmented into preserved drugs and preservative free drugs.
Based on the drug delivery types, ophthalmology drugs & devices market is divided into capsules & tablets, gels, eye drops, eye ointment and eye solutions.
Ophthalmology Drugs & Devices Market Country Level Analysis
Ophthalmology drugs & devices market is analysed and market size information is provided by country, device, drugs and drug delivery types as referenced above. The countries covered in Europe ophthalmology drugs & devices market report are Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, and Rest of Europe.
The country section of the artificial organs market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Europe ophthalmology drugs & devices market report also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Europe ophthalmology drugs & devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Europe ophthalmology drugs & devices market. The data is available for the historic period of 2010 to 2018.
Competitive Landscape and Ophthalmology Drugs & Devices Market Share Analysis
Europe ophthalmology drugs & devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Europe ophthalmology drugs & devices market.
The major players of Europe ophthalmology drugs & devices market covered in the report are Johnson & Johnson Services, Inc., Alcon, Bausch & Lomb Incorporated, Carl Zeiss AG, Ellex, HOYA Corporation, Johnson & Johnson Vision Care, Inc., Merck Sharp & Dohme Corp., NIDEK CO., LTD, Novartis AG, Pfizer Inc, F. Hoffmann-La Roche Ltd, TOPCON CORPORATION, Ziemer Ophthalmic Systems, Allergan, EssilorLuxottica, IRIDEX Corporation and Santen Pharmaceutical Co., Ltd. among other regional and domestic players. The market share data in this report is available only for Europe. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Europe Ophthalmology Drugs and Devices Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.